ecompressive craniectomy has been shown to reduce intracranial pressure (ICP) in patients with traumatic brain injury (TBI), although this does not consistently result in favorable clinical outcomes. 2 Unfavorable clinical outcomes after decompressive craniectomy for TBI have been thought to be due to cerebral edema, altered cerebral blood flow (CBF), and metabolic dysfunction. 4 At this time, more data are needed on changes in cerebral hemodynamics after decompressive craniectomy to better assist in prognostication. There are limited data on changes in microvascular cerebral perfusion after decompressive craniectomy.
outcomes after TBI, 11 clinical correlates of these metrics after decompressive craniectomy have not been explored.
The aim of the present study was to evaluate global and regional CBF patterns in relation to cerebral hemodynamic parameters in patients after decompressive craniectomy for TBI.
Methods
We studied prospectively collected clinical and imaging data for patients with TBI who underwent quantitative CBF measurements using stable xenon-enhanced CT (XeCT) imaging. XeCT CBF was performed per an investigational study protocol designed to study regional CBF after TBI. For the present study, we selected only those patients who underwent XeCT CBF studies after a decompressive craniectomy for evacuation of a mass lesion and/ or to relieve intractable intracranial hypertension. All patients were admitted to a neurosurgical intensive care unit (ICU) and managed according to the guidelines described by the Brain Trauma Foundation. Patients with mass lesions requiring emergency decompressive surgery (primary decompressive surgery) were admitted to the ICU postoperatively. Secondary decompressive surgery was performed after admission to the ICU for patients with intractable intracranial hypertension that was resistant to maximum medical therapy. Maximum medical therapy for intracranial hypertension included the use of an external ventricular drain for CSF drainage, sedation, paralytics, mannitol, and initiation of pentobarbital coma.
Demographic, clinical, and follow-up data for the patients in this study are maintained in a research database at our institution. Prehospital and admission clinical and imaging data including Glasgow Coma Scale (GCS) scores, pupillary examination, mechanism of injury, Abbreviated Injury Scale scores, 7 and initial Marshall CT classification 13 Outcomes were measured at discharge and at 6-month follow-up visits using the Glasgow Outcome Scale (GOS).
XeCT CBF studies were performed as previously described 6,17 after patients were hemodynamically stable in the ICU. Four to 6 axial slices, each 5 mm thick and 20 mm apart, from posterior fossa to vertex were obtained ( Figs.  1 and 2 ). Continuous monitoring of end-expiratory CO 2 , xenon as well as arterial blood pressure, and ICP (when available) was performed. The earliest XeCT CBF study performed after decompressive craniectomy was selected for analysis. Images were analyzed using proprietary software (Diversified Diagnostic Products, Inc.). Global CBF was measured using a preset template that demarcated the cortical mantle. Regional CBF was measured using manual regions of interest in the cortical mantle under the craniectomy for the ipsilateral decompressed cerebral hemisphere and the contralateral hemisphere.
For patients who underwent bifrontal decompressive craniectomy, the side of the larger craniectomy defect was categorized as the ipsilateral side. In 2 patients, manual regions of interest could not be drawn, and data from the preset template were used to calculate regional CBF. For 10 patients, XeCT CBF data were available prior to decompressive craniectomy, and regional and global CBF data were measured using the preset template. CBF values were categorized as core (0-8 ml/100 g/min), penumbra (9-30 ml/100 g/min), normal (31-70 ml/100 g/min), and hyperemia (> 70 ml/100 g/min).
6,11
Statistical analysis was performed using IBM SPSS version 20.0. Descriptive statistics were used for demographic and clinical data. Normality of data was determined using the Shapiro-Wilk test. Parametric comparisons for patient survival were performed using the Student t-test. Nonparametric comparisons between pre-and postcraniectomy XeCT data were performed using the Kruskal-Wallis test. Statistical significance was set at p < 0.05.
Results
Twenty-seven patients were included in this study. Eighteen patients underwent CBF studies in the ICU using a portable CT scanner, and 9 patients required transport to the main CT scanner for CBF imaging. The majority of patients (n = 18) had more than 1 XeCT CBF study, and the median number of scans was 2 per patient. Demographic, clinical, and imaging data at admission are shown in Table 1 . Three patients (11.1%) had prehospital hypoxia, and 1 patient (3.7%) had prehospital hypotension. The majority of patients (88.9%) had an initial GCS score ≤ 8. The median time between injury and decompressive surgery was 9 hours (range 1-162 hours). Primary decompressive surgery (within 24 hours) was performed in the majority of patients (n = 18, 66.7%).
XeCT CBF studies were performed a median of 51 hours (range 4-384 hours) after decompressive surgery. The mean CPP prior to XeCT CBF (n = 22) was significantly lower compared with CPP at the time of the CBF study (60.8 ± 15.5 vs 69.3 ± 16.2 mm Hg; p = 0.03). The mean ICP prior to XeCT CBF (n = 22) was higher than the ICP at the time of the CBF study (27.1 ± 13.3 vs 20.4 ± 12.7 mm Hg; p = 0.06). Comparisons for PbtO 2 and SjvO 2 values showed no significant difference (p = 0.47 and p = 0.28, respectively; n = 9) at the 2 time points. The PbtO 2 probe was adjacent to a cortical contusion in 3 patients who died and 3 patients who survived. In the rest of the patients, the probe was in normal-appearing cortex.
The mean global CBF after decompressive craniectomy was 49.9 ± 21.3 ml/100 g/min. The mean cortical CBF under the craniectomy defect was 46.0 ± 21.7 ml/100 g/min. There was no significant difference in the mean hemispheric CBF ipsilateral to the craniectomy versus contralateral to the craniectomy defect (47.7 ± 22.4 vs 51.1 ± 22.4 ml/100 g/min; p = 0.17). Categorized CBF values after decompressive surgery are shown in Table 2 .
Comparisons of pre-and postcraniectomy global CBF showed a higher CBF after surgery in 10 patients; however, the difference was not statistically significant (44.8 ± 11.7 vs 49.7 ± 13.4 ml/100 g/min; p = 0.16) (Fig. 3) . Prior to craniectomy, 9 patients had normal CBF (31-70 ml/100 g/ min), and 1 patient had low/penumbra CBF (9-30 ml/100 g/min). After decompressive surgery, low CBF persisted in 1 patient, 8 patients had normal CBF, and 1 patient had hyperemia (> 70 ml/100 g/min).
At discharge from the hospital, 6 patients had died, 8 patients were in a persistent vegetative state, and 12 patients had severe disability. No GOS score was recorded for 1 patient at discharge. At 6 months follow-up, 7 patients were dead, 2 patients were in a persistent vegetative state, 8 patients had severe disability, 5 patients had moderate disability, and 1 patient had good recovery. Four patients were lost to follow-up at 6 months. Patients who were dead at discharge had significantly lower postcraniectomy CBF under the craniectomy (30.1 ± 22.9 vs 50.6 ± 19.6 ml/100 g/min; p = 0.039). These patients also had lower global CBF (36.7 ± 23.4 vs 53.7 ± 19.7 ml/100 g/min; p = 0.09), as well as lower CBF for the ipsilateral (33.3 ± 27.2 vs 51.8 ± 19.7 ml/100 g/min; p = 0.07) and contralateral (36.7 ± 19.2 vs 55.2 ± 21.9 ml/100 g/min; p = 0.08) hemispheres, but these differences were not statistically significant (Fig.  4) . There was no significant difference in the mean arterial pressure between the groups (85 ± 4.6 vs 91.2 ± 9.2 mm Hg; p = 0.13). Patients who died also had significantly lower CPP (52 ± 17.4 vs 75.3 ± 10.9 mm Hg; p = 0.001).
Postoperative ICP was higher (33 ± 16.8 vs 16.1 ± 6.4 mm Hg; p = 0.06) and PbtO 2 was lower (6 ± 5.8 vs 24.5 ± 17.3 mm Hg; p = 0.06) in the mortality group, although these differences were not significantly different (Fig. 5) . CBF values were compared for patients with favorable GOS scores (good recovery and moderate disability) and unfavorable GOS scores (death, persistent vegetative state, and severe disability) at 6 months. There were no significant differences in global CBF (50.2 ± 30.7 vs 46.9 ± 20.1 ml/100 g/min; p = 0.76), CBF under craniectomy defect (53.6 ± 29.9 vs 41.6 ± 19.9 ml/100 g/min; p = 0.28), ipsilateral hemispheric CBF (51.9 ± 29.8 vs 44.9 ± 21.9 ml/100 g/min; p = 0.55), and contralateral hemispheric CBF (49.3 ± 29.8 vs 49.0 ± 21.7 ml/100 g/min; p = 0.98).
Discussion
This study describes patterns of global and regional CBF visualized on XeCT CBF studies after decompressive craniectomy for TBI. In the presence of global hypoperfusion, regional cerebral hypoperfusion after decompressive craniectomy was significantly associated with early mortality after TBI. These findings were corroborated by impaired cerebral hemodynamics.
Few studies have described quantitative CBF patterns in patients who have undergone decompressive craniecto- my for TBI. 12 We used XeCT, which is a well-established modality to quantify global and regional CBF and has been used to predict clinical outcomes in TBI.
6,9,11 The majority of patients (81.5%) had normal and hyperemic global CBF values after decompressive craniectomy. Similarly, normal and hyperemic CBF values were observed under the craniectomy and on the ipsilateral cerebral hemisphere (in 70.4% of patients). XeCT was able to demonstrate regions of persistent hypoperfusion under the craniectomy defect, which probably represented areas of contusion and devitalized brain. Yamakami and Yamaura 16 used SPECT imaging in 5 patients after decompressive craniectomy and showed transient focal hyperperfusion in the decompressed brain that lasted at least 1 week after decompressive craniectomy. In a pilot study, Heppner et al. used contrast-enhanced ultrasound to study microvascular cerebral perfusion after decompressive craniectomy in 6 patients; they showed increased CBF and cerebral blood volume up to 48 hours after surgery. Contrast-enhanced ultrasound, however, is restricted to measuring regional CBF and has not been validated with standard techniques to measure CBF. Other studies using transcranial Doppler to measure macrovascular flow after decompressive craniectomy have shown increased flow velocities in both hemispheres after surgery.
3,5
Decompressive craniectomy for patients with TBI has been shown to produce favorable effects on cerebral hemodynamics, particularly a decrease in ICP and an increase in CPP. 2 We found that CPP was significantly increased after surgery compared with before decompressive surgery. Improvements in brain oxygen tension have also been noted after decompressive craniectomy, indicating improved oxygen delivery to brain tissue. 10, 15 A normal ICP with a low PbtO 2 after decompressive craniectomy, however, is associated with a poor outcome.
In the present study, the majority of patients who died had a mismatch between ICP and PbtO 2 , as well as hypoperfusion on XeCT CBF. Two patients who died after decompressive craniectomy had ICP values ≤ 22 mm Hg, but PbtO 2 < 5 mm Hg after surgery. Two additional patients who died had mildly elevated ICP (24 mm Hg) and low PbtO 2 (< 15 mm Hg) after decompressive craniectomy. Optimizing the timing of decompressive craniectomy may restore CBF and PbtO 2 in addition to reducing ICP and increasing CPP. Continued multimodal monitoring after decompressive craniectomy for TBI can detect persistent metabolic dysfunction and help guide further management and prognosis.
There are limited data on CBF patterns before and after decompressive craniectomy for TBI. Soustiel et al. 14 used ultrasound to measure CBF before and after decompressive craniectomy in 7 patients and found a significant increase of approximately 4 ml/100 g/min. Using transcranial Doppler, Daboussi et al. 5 showed an immediate, symmetric increase in CBF velocities in patients before and after decompressive craniectomy. In the present study, among the 10 patients with pre-and postcraniectomy CBF studies, CBF decreased in 2 patients, and low CBF before surgery persisted after decompressive craniectomy in 1 patient. These data point to a subset of patients who showed no improvement or worsened CBF after decompressive craniectomy. Further study is needed to determine whether precraniectomy CBF studies can help optimize the timing of decompressive craniectomy.
This study is limited by the small sample size and its retrospective design. These preliminary results show an association between low CBF and mortality and can help investigate mismatches between ICP and PbtO 2 data after decompressive craniectomy. CBF studies may help to explain poor outcomes in future clinical trials for decompressive craniectomy in TBI. Presurgical CBF studies may have value in the selection and timing of secondary decompressive craniectomy in patients with diffuse injury and intractable intracranial hypertension.
Although XeCT CBF can produce high-resolution images of global and regional CBF in the brain, it has technical limitations; these include a relatively low signal-tonoise ratio, large slice thickness, and signal averaging, as well as the potential for xenon to variably activate CBF.
17
Because xenon is not used clinically, other CBF measurement techniques (e.g., thermal diffusion microprobes, SPECT, PET, or CT perfusion 1 ) can be used to further build on the results of this study. A larger sample size would have enabled us to perform a subgroup analysis for different types of decompressive craniectomy in addition to primary and secondary decompressive craniectomy. Overall, we used multimodal monitoring and XeCT CBF to describe cerebral hemodynamics after decompressive craniectomy and identified factors associated with early mortality.
Conclusions
The majority of patients (81.5%) had normal and hyperemic global CBF after decompressive craniectomy. Persistent cerebral hypoperfusion after decompressive craniectomy was associated with early mortality after severe TBI. Further study is needed to determine the value of incorporating CBF studies into clinical decision making for severe TBI.
